ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,556Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 336

$567K Total Retail Price of All Prescriptions

Rank: 129 out of 336

459 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 11,386 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 662 639 1 3
AMLODIPINE BESYLATE 559 528 2 1
PRAVASTATIN SODIUM 518 492 3 10
SIMVASTATIN 423 397 4 5
LEVOTHYROXINE SODIUM 414 366 5 7
LISINOPRIL 352 325 6 6
GABAPENTIN 317 268 7 11
HYDROCODONE-ACETAMINOPHEN 307 220 S3 8 2
LOSARTAN POTASSIUM 301 301 9 22
FUROSEMIDE 290 268 10 4
POTASSIUM CHLORIDE 271 247 11 9
TRIAMTERENE-HCTZ 248 219 12 35
SYNTHROID 241 214 13 43
HYDROCHLOROTHIAZIDE 240 211 14 12
EVISTA 204 203 15 106
TRAMADOL HCL 204 169 15 20
METOPROLOL SUCCINATE 192 186 17 15
KLOR-CON M20 180 164 18 51
ATENOLOL 168 146 19 26
METOPROLOL TARTRATE 167 145 20 16
METFORMIN HCL ER 146 109 21 61
CITALOPRAM HBR 143 118 22 21
ZOLPIDEM TARTRATE 142 122 23 18
SERTRALINE HCL 128 118 24 33
METFORMIN HCL 113 89 25 8
LOSARTAN-HYDROCHLOROTHIAZIDE 111 111 26 45
NEXIUM 108 108 27 24
FLUTICASONE PROPIONATE 106 103 28 49
CRESTOR 99 79 29 25
PANTOPRAZOLE SODIUM 97 95 30 40
CLONIDINE HCL 93 76 31 32
VERAPAMIL ER 93 93 31 95
ATORVASTATIN CALCIUM 92 83 33 14
ZETIA 87 87 34 74
CARVEDILOL 82 82 35 13
HYDRALAZINE HCL 78 78 36 53
PROPRANOLOL HCL 77 77 37 101
DIOVAN 75 75 38 31
DONEPEZIL HCL 74 72 39 27
CLOPIDOGREL 74 68 39 28
DIOVAN HCT 73 73 41 41
TAMSULOSIN HCL 69 67 42 38
ALLOPURINOL 69 69 42 30
SPIRONOLACTONE 69 69 42 42
LEVOXYL 67 55 45 180
TRICOR 65 65 46 108
LANTUS 63 63 47 56
TRAZODONE HCL 63 56 47 46
ISOSORBIDE MONONITRATE ER 60 53 49 44
AZITHROMYCIN 57 49 50 58
CIPROFLOXACIN HCL 54 52 51 55
PLAVIX 52 50 52 37
GLIMEPIRIDE 51 43 53 29
PREMARIN 51 51 R 53 131
CLOTRIMAZOLE-BETAMETHASONE 50 33 55 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.